Skip to main content
SpringerLink
Log in

Cefotaxime: Efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci

Wirksamkeit und Verträglichkeit von Cefotaxim bei tiefen Atemwegsinfektionen durch gram-positive Kokken

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Cefotaxime is an effective antibiotic in lower respiratory tract infection caused by streptococci and staphylococci. There is a limited tendency to superinfections withPseudomonas aeruginosa (1.5%) and there is a low incidence of side-effects. It is questionable whether there is really an urgent need for cefotaxime in gram-positive lower respiratory tract infections.

Zusammenfassung

Cefotaxim erwies sich als wirksames Antibiotikum zur Behandlung von tiefen Atemwegsinfektionen durch Staphylokokken und Streptokokken. Es bestand eine begrenzte Tendenz zu Superinfektionen mitPseudomonas aeruginosa (1.5%). Die Verträglichkeit war gut. Sicherlich ist Cefotaxim nicht Mittel der ersten Wahl bei gram-positiven Infektionen des tiefen Atemtraktes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literature

  1. Lode, H., Kemmerich, B., Gruhlke, G., Dzwillo, G. Cefotaxime in bronchopulmonary infections — a clinical and pharmacological study. J. Antimicrob. Chemother. 6 Suppl. A (1980) 193–198.

    Google Scholar 

  2. Karakusis, P. H., Feczko, J., Goodman, L. J., Hanlon, D. M., Harris, A. A., Levin, S., Trenholme, G. M. Clinical efficacy of cefotaxime in serious infections. Antimicrob. Agents Chemother. 21 (1982) 119–124.

    Google Scholar 

  3. Jenkinson, S. G., Briggs, M. S., Bryn, R. D. Cefotaxime in the treatment of pneumococcal pneumonia. J. Antimicrob. Chemother. 6 Suppl. A (1980) 177–180.

    Google Scholar 

  4. Berman, T. M., Kronenberg, R. S. Cefotaxime treatment of lower respiratory tract infections in patients with underlying lung diseases. Cefotaxime sodium, a new cephalosporin. Current Research Symposium, January 1981, Drug Therapy 3 Suppl. (1981) 35–39.

    Google Scholar 

  5. Beumer, H. M., Veldkamp, J., Deleers, L. Cefotaxime in the treatment of lower respiratory tract infections. Int. J. Clin. Pharmacol. Ther. Toxicol. 21 (1983) 605–610.

    Google Scholar 

  6. Francke, E. L., Neu, H. C. Use of cefotaxime, aβ-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. Am. J. Med. 71 (1981) 435–442.

    Google Scholar 

  7. Geckler, R. W., Salkeld, J. W., Goodman, J. S. Cefotaxime therapy of lower respiratory tract infections. Cefotaxime sodium, a new cephalosporin: Current Research Symposium, January 1981, Drug Therapy 3 Suppl. (1981) 35–39.

    Google Scholar 

  8. Graninger, W., Breyer, S., Pichler, H., Rameis, H., Diem, E., Boehm, M., Spitzy, K. H. Cefotaxime:In vitro activity against cephalothin-resistant isolates and use in the treatment of septicemia, pneumonia, urinary tract and other severe infections. Infection 9 (1981) 29–33.

    Google Scholar 

  9. Grassi, C., Colombo, M. L., Peona, V. The use of cefotaxime in pneumology. Acta Médica Portuguesa 4 (1983) 87–90.

    Google Scholar 

  10. Hänninen, P., Toivanen, A., Vainio, O., Toivanen, P. Cefotaxime in the treatment of lower respiratory tract infections. J. Antimicrob. Chemother. 6 Suppl. A (1980) 181–185.

    Google Scholar 

  11. Jenkinson, S. G., Briggs, M. S., Bryn, R. D. Low-dose cefotaxime therapy in the treatment of pneumococcal pneumonia. J. Antimicrob. Chemother. 6 Suppl. A (1980) 177–180.

    Google Scholar 

  12. Keelan, P., Hone, R., Martin, L., Callaghan, B., Harty, M. Cefotaxime in the management of acute lower respiratory tract infection. Irish Med. J. 75 Suppl. (1982) 6–7.

    Google Scholar 

  13. Kosmidis, J., Daikos, G. K. Prospective randomized comparative studies of mezlocillin/cefotaxime vs. gentamicin/cefoxitin. J. Antimicrob. Chemother. 11 Suppl. C (1983) 91–95.

    Google Scholar 

  14. Lopez, E. L., Bonesana, N. F., Rubeglio, E., Schugurensky, A. Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms. J. Antimicrob. Chemother. 6 Suppl. A (1980) 249–253.

    Google Scholar 

  15. Miki, F., Shiota, K. Cefotaxime in lower respiratory tract infections compared to cefazolin. J. Antimicrob. Chemother. 6 Suppl. A (1980) 169–175.

    Google Scholar 

  16. Papadatos, C. J., Kefetzis, D. A., Kanarios, J. Cefotaxime in the treatment of severe paediatric infections. J. Antimicrob. Chemother. 6 Suppl. A (1980) 243–248.

    Google Scholar 

  17. Perkins, R. L. Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract. Rev. Infect. Dis. 4 (1982) 421–431.

    Google Scholar 

  18. Schleupner, C. J., Engle, J. C. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections. Antimicrob. Agents Chemother. 1 (1982) 327–333.

    Google Scholar 

  19. Schwigon, C. D. Cefotaxim: Eine Alternative zur Kombinationstherapie bei fehlendem Keimnachweis bei nosokomialen Infektionen in der Intensivmedizin. Infection 8 (1980) 469–472.

    Google Scholar 

  20. Shah, P. M., Helm, E. B., Stille, W. Klinische Erfahrungen mit Cefotaxim, einem neuen Cephalosporin-Derivat. Med. Welt 30 (1979) 298–301.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department of the Klinikum Steglitz, Freie Universität Berlin, Hindenburgdamm 30, D-1000, Berlin 45

    H. Lode M. D. &  P. D. Glatzel

Authors
  1. H. Lode M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. D. Glatzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lode, H., Glatzel, P.D. Cefotaxime: Efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci. Infection 13 (Suppl 1), S25–S27 (1985). https://doi.org/10.1007/BF01644213

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01644213

Keywords

Search

Navigation